Rupam Manna/LinkedIn
May 25, 2026, 14:57
Rupam Manna: Approach and Management of Deep Vein Thrombosis in Cancer
Rupam Manna, Postdoctoral Student – DrNB Medical Oncology at National Board of Examinations, shared a post on LinkedIn:
“Deep Vein Thrombosis (DVT) in Oncology is more than just a clot — it reflects the profound hypercoagulable state created by cancer itself.
From Virchow’s triad to modern anticoagulation strategies, understanding cancer-associated thrombosis is essential for every oncologist and physician.
- Always suspect DVT in any cancer patient with new unilateral swelling.
- Balance thrombosis risk against bleeding risk carefully.
- Early recognition saves lives.
Key concepts covered:
- Why cancer causes thrombosis
- High-risk cancers and drugs
- Diagnosis and Doppler approach
- LMWH vs DOACs
- Duration of anticoagulation
- Special situations: thrombocytopenia, brain mets, incidental PE and DVT”
Stay updated with Hemostasis Today.
-
May 25, 2026, 15:01Abdirahman K. Mohamud: A New Continental Plan for Sickle Cell Disease in Africa
-
May 25, 2026, 15:00Tahsim Anwar: Highlighting Transfusion Therapy as a Cornerstone in the Management of SCD Complications
-
May 25, 2026, 14:59Nimesh Patel: Understanding Plasmapheresis – A Clinical Overview
-
May 25, 2026, 14:58Samwel Mikaye: Pathophysiology, Clinical Features and Management of CAD
-
May 25, 2026, 14:56Andrea Fischer: Celebrating Hematology Advocacy Recognition and New Achievements This Spring
-
May 25, 2026, 14:45Monica Schaller: How Do Autophagy, Inflammation, and NETs Interact to Drive Autoimmune Thrombosis?
-
May 25, 2026, 14:04Sophia Delicou: We Aim to Bridge Laboratory Insights and Clinical Practice for Unstable Hemoglobin Variants
-
May 25, 2026, 13:49Chaitanya Harita: Presenting AML Research at the British Society for Haematology Annual Scientific Meeting 2026
-
May 25, 2026, 13:04Mohammad Ameen Ishqair: Blood Group Antigens as Emerging Biomarkers in Disease